Skip to main content

HEALTH

  • Abbott boosts EAS brand with new products for athletes

    ABBOTT PARK, Ill. — Abbott on Wednesday announced that its EAS sports nutrition brand has launched a new line of performance nutrition products.

    The lineup includes EAS Recovery protein powder, EAS Lean 15 protein powder, EAS Myoplex original with Revigor and EAS Myoplex 30 bars. All of the products are designed to rapidly deliver needed nutrients to fatigued muscles and help athletes recover and build muscle, the company said.

  • Walgreens outlines results of medication adherence studies

    DEERFIELD, Ill. — Walgreens unveiled the results of research, conducted by the drug store chain, that demonstrated how its approach to community pharmacy ultimately helped improve outcomes through cost savings, pharmacist-led face-to-face patient counseling and specialized services for disease management.

    New research results, presented by Walgreens at the Academy of Managed Care Pharmacy's 24th Annual Meeting and Expo last week in San Francisco, included:

  • CHPA leader urges House subcommittee to restore FSA OTC coverage

    WASHINGTON — The Consumer Healthcare Products Association on Wednesday testified before a House subcommittee to urge legislators to restore over-the-counter medicines' eligibility under flexible spending accounts.

  • Luna debuts fiber bar line

    EMERYVILLE, Calif. — Luna has introduced a high-fiber snack that provides women with the essential nutrients they need most.

    The soft-baked and fruit-filled bar, available in peanut butter strawberry, blueberry vanilla and chocolate raspberry flavors, touts 7 g of fiber, as well as calcium, folic acid, iron and vitamin D. Each bar contains 110 to 120 calories each, the company said.

    Luna Fiber will be available in stores nationwide in May for a suggested retail price of $1.39.

  • Reports: GSK calls $2.6 billion offer for Human Genome Sciences 'full and fair'

    NEW YORK — GlaxoSmithKline said its offer to buy Human Genome Sciences was "full and fair" Wednesday after HGS turned it down last week, according to published reports.

    Reuters reported that GSK's $13-per-share, $2.6 billion offer for HGS would give the former full control of Benlysta (belimumab), the first new drug approved by the Food and Drug Administration for lupus in more than half a century. The two companies developed the drug together under a partnership, and the drug received approval in March 2011.

  • CRN, FMI partner on educational tool for pharmacists

    WASHINGTON — The Council for Responsible Nutrition and the Food Marketing Institute announced they are working together to remind pharmacists about their legal obligations when selling dietary supplements in a retail setting.

  • FDA outlines global food, drug, device safety strategy

    SILVER SPRING, Md. — Globalization has led to a rapid increase in the drugs and foods arriving on U.S. shores from abroad, a trend that has prompted U.S. regulators to transform their approach.

    The Food and Drug Administration released a report Monday detailing its strategies for what it called transforming from a domestic to a global public health agency.

  • CVS/pharmacy featured on 'The Doctors'

    WOONSOCKET, R.I. — CVS/pharmacy took center stage on the latest episode of "The Doctors," as one of the chain's pharmacists sat down with one of the show's co-hosts to discuss how patients can manage diabetes on a budget.

    Speaking with emergency room physician Dr. Travis Stork, CVS pharmacist Usheema Thomas told an audience member that recently was diagnosed with diabetes how to manage her condition by using a blood-glucose monitoring system. Thomas also discussed CVS/pharmacy's free ExtraCare for Diabetes program and the benefits of enrolling into the program.

X
This ad will auto-close in 10 seconds